Titan Bio-Tech shareholders and shareholding pattern
BSE: 524717Chemicals & PetrochemicalsSmall Cap
Titan Bio-Tech Ltd. · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994
Last close ₹339.85down ₹20.60 (5.72%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹360.45.
30 Oct: open ₹364.90, high ₹364.95, low ₹335.40
52-week range of traded prices to 30 Oct 2026
₹137.12Low, 9 Dec 2025₹444.52High, 7 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,755 Cr1,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 51.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.67
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 49,199
Titan Bio-Tech's shareholding pattern for Sep 2026, filed on 14 Oct 2026, with every filing from Dec 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Titan Bio-Tech, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters55.78%
- Indian institutions0.01%
- Individuals and others44.21%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Indian institutions
- Individuals and others
| Per cent | Dec 2016 | Mar 2017 | Jun 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Dec 2023 | Jun 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.01% | 48.00% | 48.00% | 48.00% | 48.00% | 48.00% | 48.00% | 49.49% | 49.49% | 49.73% | 54.35% | 54.35% | 54.40% | 54.24% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.78% | 55.78% | 55.78% | 55.78% | 55.78% | |
| Indian promoters | 48.01% | 48.00% | 48.00% | 48.00% | 48.00% | 48.00% | 48.00% | 49.49% | 49.49% | 49.73% | 54.35% | 54.35% | 54.40% | 54.24% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.88% | 55.78% | 55.78% | 55.78% | 55.78% | 5.92% |
| Foreign promoters | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 49.86% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 51.99% | 52.00% | 52.00% | 52.00% | 52.00% | 52.00% | 52.00% | 50.51% | 50.51% | 50.27% | 45.65% | 45.65% | 45.60% | 45.76% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.12% | 44.22% | 44.22% | 44.22% | 44.22% | 44.22% |
| Shares in issue | 77,38,700 | 77,38,700 | 77,38,700 | 77,38,700 | 77,38,700 | 77,38,700 | 77,38,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 82,63,700 | 4,13,18,500what Shares in issue, Mar 2026, includes. Split on 20 Feb 2026: each share became 5. Earlier filings count the shares before it. | 4,13,18,500 | 4,13,18,500 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 3,50,000 | 3,50,000 | 3,50,000 | 3,50,000 | – | – | 36,18,831 | 41,43,831 | 41,43,831 | 41,33,831 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Promoters' shares locked in | 3,50,000 | 3,50,000 | 3,50,000 | 3,50,000 | – | – | 24,43,831 | 28,18,831 | 28,18,831 | 28,18,831 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | 3,75,000 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Titan Bio-Tech promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Titan Securities Limited, 33.59%. The filing names 2 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Titan Securities LimitedForeign companies and others | 33.59% | 1,38,80,775 |
| Tanita Leasing & Finance LimitedForeign companies and others | 9.49% | 39,22,275 |
| Connoisseur Management Services Private LimitForeign companies and others | 6.78% | 28,00,000 |
| Suresh Chand SinglaIndividuals and Hindu undivided families | 1.28% | 5,28,355 |
| Manju SinglaIndividuals and Hindu undivided families | 0.86% | 3,56,050 |
| Madhu GuptaIndividuals and Hindu undivided families | 0.80% | 3,32,550 |
| Raja SinglaIndividuals and Hindu undivided families | 0.74% | 3,05,500 |
| Supriya SinglaIndividuals and Hindu undivided families | 0.66% | 2,72,465 |
| Udit SinglaIndividuals and Hindu undivided families | 0.61% | 2,50,000 |
| Shivom SinglaIndividuals and Hindu undivided families | 0.43% | 1,77,000 |
| Naresh Kumar SinglaIndividuals and Hindu undivided families | 0.42% | 1,72,550 |
| Naresh Kumar Singla HUFIndividuals and Hindu undivided families | 0.12% | 50,000 |
No promoter shares are reported as pledged.
Largest public holders of Titan Bio-Tech, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2019 | Jun 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Dec 2023 | Jun 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRSInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.37% |
| Manish GoelResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.65% | 1.74% | 2.62% | 2.80% | 2.80% | 2.80% | 2.81% |
| TITAN BIOTECH LIMITED UNCLAIMED SUSPENSE DEMAT ACCOUNTCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.51% | – | 2.30% |
| Investor Education and Protection Fund AuthorInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.51% | – |
| Titan Biotech Limited Unclaimed Suspense DemaCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.36% | – |
| Investor Education and Protection Fund AuthorityInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.24% | 9.63% | 9.58% | – | – |
| Mukesh PanjwaniResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.03% | 1.15% | – | – | – | – | – | – | – |
| Avb Shares Trading Private LimitedOther non-institutions | 16.03% | 16.03% | 14.91% | 14.87% | 14.44% | 4.98% | 1.43% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| White Diamand Enterprises Private LimitedOther non-institutions | – | – | – | – | 1.39% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| White Diamand Media and Advertisment Private LimitedOther non-institutions | – | – | 1.39% | 1.39% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| S. Udit Securities Pvt Ltd.Other non-institutions | 10.42% | 9.95% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: Investor Education and Protection Fund Author no longer named, from 9.51%; INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS newly named at 9.37%; Titan Biotech Limited Unclaimed Suspense Dema no longer named, from 2.36%; 2 more moved